Cingulate is a biopharmaceutical company creating a pipeline of next-generation treatments utilizing its innovative Precision Timed Release™ technology.
Welcome @CingulateInc (NASDAQ:$CING) to the Maxim Group's Virtual Healthcare Conference hubs.li/Q01TBRjp0 Cingulate Inc. is a biopharmaceutical company utilizing its proprietary PTR™ drug delivery platform technology to improve the lives of patients.
youtu.be/k492DMuH5cY@CingulateInc$CING is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. CEO Shane Schaffer. #adhd#anxiety